CVS is voluntarily removing certain cough and cold medicines that contain phenylephrine as the only active ingredient from stores.
CVS is voluntarily removing some of the most common cough and cold medicines from its store shelves and will no longer sell them, a company spokesperson told CNBC on Thursday.
The FDA has not decided whether to ask drug manufacturers and retailers such as CVS to remove products containing oral phenylephrine from the market.is removing some of the most common cough and cold medicines from its store shelves and will no longer sell them, a company spokesperson told CNBC on Thursday.
Feeling out of the loop? We'll catch you up on the Chicago news you need to know. Sign up for the weeklyHowever, CVS is voluntarily removing certain cough and cold medicines that contain phenylephrine as the only active ingredient from stores.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Rite Aid, CVS, Walgreens close hundreds of stores amid rising pressureDrugstores did well during the pandemic due to COVID-19 vaccinations, but are now seeing less foot traffic and fewer prescriptions.
Weiterlesen »
CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling ThemMove comes a month after FDA advisers said the common ingredient phenylephrine is ineffective
Weiterlesen »
CVS is pulling some cold medicines from store shelvesCVS won't sell decongestants that only contain phenylephrine as an active ingredient after an FDA panel called the ingredient ineffective.
Weiterlesen »
CVS voluntarily pulling decongestants from shelves that contain ineffective ingredientWallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.
Weiterlesen »
CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling ThemMove comes a month after FDA advisers said the common ingredient phenylephrine is ineffective
Weiterlesen »